September 21, 2010
Vitae Pharmaceuticals to present at UBS Global Life Sciences Conferences in New York.
September 15, 2010
Vitae Pharmaceuticals to present at Stifel Nicolaus Healthcare Conference in Boston.
July 14, 2010
Vitae Pharmaceuticals Hires Christine Brennan, Ph.D. as Chief Business Officer
Vitae Pharmaceuticals is a world leader in structure-based drug discovery (SBDD), combining our proprietary discovery engine with an integrated team of expert chemists, biologists and clinicians, to solve today's toughest and most promising drug discovery challenges.
Vitae Pharmaceuticals' SBDD approach is delivering strong performance results not only in terms of program success, but also on key criteria important to discovery organizations throughout the industry: innovation, speed and capital efficiency.
Vitae Pharmaceuticals is a clinical stage biopharmaceutical company building a portfolio of novel, small molecule, best-in-class compounds that address large market opportunities, including chronic kidney disease, diabetes, atherosclerosis and Alzheimer's disease.